IL6 and breast carcinoma: In contrast, the expression of ZEB2 was generally low in breast cancer cells compared to THP‐1 cells, an acute myelogenous leukemia cell line with known ZEB2 function (Li et al., 2017), and showed weaker correlation with IL6 and IL8 expression than that of ZEB1 (Fig. S3A).